Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 29 of 29 publications.

Mansfield C, Ho KA, Pierce A, Vass C, Liu X, Boroojerdi B, Kiri S. Patient preferences for myasthenia gravis treatments: a discrete-choice experiment. Poster presented at the American Academy of Neurology (AAN) Annual Meeting 2024; April 2024. Denver, CO. [abstract] Neurology. 2024 Apr 9; 102(17 Supplement 1). doi: 10.1212/WNL.0000000000206306

Krege JH, Gilsenan AW, Komacko JL, Kellier-Steele N. Teriparatide and osteosarcoma risk: history, science, elimination of boxed warning, and other label updates. J Bone Miner Res. 2022 Aug 14;6(9):e10665. doi: 10.1002/jbm4.10665

Skajaa N, Adelborg K, Horvath-Puho E, Rothman KJ, Henderson VW, Thygesen LC, Sorensen HT. Risks of stroke recurrence and mortality after first and recurrent strokes in Denmark: a nationwide registry study. Neurology. 2021 Nov 29. doi: 10.1212/WNL.0000000000013118

Skajaa N, Adelborg K, Horvath-Puho E, Rothman KJ, Henderson VW, Thygesen LC, Sorensen HT. Nationwide trends in incidence and mortality of stroke among younger and older adults in Denmark. Neurology. 2021 Mar 30;96(13):e1711-23. doi: 10.1212/WNL.0000000000011636

Amato AA, Hanna MG, Machado PM, Badrising UA, Chinoy H, Benveniste O, Karanam AK, Wu M, Tanko LB, Schubert-Tennigkeit AA, Papanicolaou DA, Lloyd TE, Needham M, Liang C, Reardon KA, de Visser M, Ascherman DP, Barohn RJ, Dimachkie MM, Miller JAL, Kissel JT, Oskarsson B, Joyce NC, Van den Bergh P, Baets J, De Bleecker JL, Karam C, David WS, Mirabella M, Nations SP, Jung HH, Pegoraro E, Maggi L, Rodolico C, Filosto M, Shaibani AI, Sivakumar K, Goyal NA, Mori-Yoshimura M, Yamashita S, Suzuki N, Aoki M, Katsuno M, Morihata H, Murata K, Nodera H, Nishino I, Romano (DeMuro) C, Williams VSL, Vissing J, Auberson LZ, RESILIENT Study Extension Group . Efficacy and safety of Bimagrumab in sporadic inclusion body Myositis: long-term extension of RESILIENT. Neurology. 2021 Mar 23;96(12):e1595-607. doi: 10.1212/WNL.0000000000011626

Stuckey HL, Oser SM, Miller EL, Oser TK, Peyrot M, Sharma A. “Not today, diabetes”: using blog analysis to understand emotional interactions and support among people with type 1 diabetes. Front Clin Diabetes Healthc. 2021 Jan 6;1:613569. doi: 10.3389/fcdhc.2020.613569

Anderson-Smits C, Layton JB, Ritchey ME, Hayden V, Sehinovych I, Chavan S, Souayah N. Patient and treatment characteristics of a large US sample of patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) initiating Intravenous Immunoglobulin (IVIG) therapy. Poster presented at the 2020 Virtual American Academy of Neurology Annual Meeting (Conference cancelled); April 25, 2020. Toronto, Canada. [abstract] Neurology. 2020 Apr 14; 94(15 Supplement):4442.

Gilsenan A, Midkiff K, Harris D, Kellier-Steele N, McSorley D, Andrews EB. Teriparatide did not increase adult osteosarcoma incidence in a 15-year US postmarketing surveillance study. J Bone Miner Res. 2020 Feb;36(2):244-51. doi: 10.1002/jbmr.4188

Raspa M, Sacco P, Bailey, Jr DB, Visootsak J, Cabo R. Clinical unmet needs and burden in fragile X syndrome: results of a targeted literature review. Poster presented at the 2018 70th Annual AAN Meeting; April 24, 2018. Los Angeles, CA. [abstract] Neurology. 2018 Apr 10; 90(15 Supplement):3.314. Previously presented at the American Association on Intellectual and Development Disabilities 141st Annual Meeting.

P Sacco, Raspa M, Leahy L, Cabo R. A literature review of the economic burden of Fragile X Syndrome. Poster presented at the 70th AAN Annual Meeting; April 24, 2018. Los Angeles, CA. [abstract] Neurology. 2018 Apr 10; 90(15 Supplement):3.319.

Yosipovitch G, Reaney M, Eckert L, Nelson L, Clark M, Abbe A, Ardeleanu M, Radin A, Gadkari A. Validation of the peak pruritus numerical rating scale: results from clinical studies of dupilumab in adults with moderate-to-severe atopic dermatitis. Poster presented at the Australasian College of Dermatologists 50th Annual Scientific Meeting; May 2017. Sydney, Australia. [abstract] Australas J Dermatol. 2017 May; 58(S1):106-7. Previously presented at the 2017 American Academy of Dermatology Annual Meeting. doi: 10.1111/ajd.21_12652

Nazareth T, Purser M, Bhaila R, Philbin M, Mladsi D. The economic burden of moderate-to-severe multiple sclerosis relapse in the United States: findings from a systematic literature review. Poster presented at the 69th AAN Annual Meeting; April 2017. Boston, MA. [abstract] Neurology. 2017 Apr 18; 88(16 Suppl).

Spelman LJ, Lebwohl M, Mordin M, Mallya UG, Gnanasakthy A, Fox T. Secukinumab treatment provides fast relief from patient-reported psoriasis burden. Poster presented at the 48th Australasian College of Dermatologists Annual Scientific Meeting; May 2015. Adelaide, Australia. [abstract] Australas J Dermatol. 2015 May; 56(Suppl 2):73.

Foley P, Sherif B, Mallya UG, Fox T, Gottlieb AB. Secukinumab treatment sustains patient-reported outcome benefits through 1 year. Poster presented at the 48th Australasian College of Dermatologists Annual Scientific Meeting; May 2015. Adelaide, Australia. [abstract] Australas J Dermatol. 2015 May; 56(Suppl 2):56.

Sinclair R, McLeod L, Mallya UG, Fox T, Strober B. Psoriasis patients with PASI90 response achieve greater health-related quality of life improvements than those with PASI75 response. Poster presented at the 48th Australasian College of Dermatologists Annual Scientific Meeting; May 2015. Adelaide, Australia. [abstract] Australas J Dermatol. 2015 May; 56(S2):68.

Webb S, Ware JE, Forsythe A, Yang M, Badia X, Nelson LM, Signorovitch JE, McLeod L, Maldonado M, Zgliczylski W, De Block C, Portocarrero-Ortiz L, Gadelha MR. Treatment effectiveness of pasireotide on health-related quality of life in patients with Cushing's disease. Eur J Endocrinol. 2014 Jul;171(1):89-98. doi: 10.1530/EJE-13-1013

Samelson EJ, Miller PD, Christiansen C, Daizedeh NS, Grazette L, Anthony MS, Egbuna O, Wang A, Siddhanti SR, Cheung AM, Franchimont N, Kiel DP. RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular risk. J Bone Miner Res. 2014 Feb;29(2):450-7. doi: 10.1002/jbmr.2043

Andrews EB, Gilsenan AW, Midkiff K, Sherrill B, Wu Y, Mann BH, Masica D. The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years. J Bone Miner Res. 2012 Dec;27(12):2429-37. doi: 10.1002/jbmr.1768

Pellock JM, Carman WJ, Thyagarajan (Hoffman) V, Daniels T, Morris DL, D'Cruz O. Efficacy of antiepileptic drugs in adults predicts efficacy in children: a systematic review. Neurology. 2012 Oct 2;79(14):1482-9. doi: 10.1212/WNL.0b013e31826d5ec0

Alvarez-Pedrerol M, Guxens M, Mendez M, Canet Y, Martorell R, Espada M, Plana E. Iodine levels and thyroid hormones in healthy pregnant women and birth weight of their offspring. Eur J Endocrinol. 2009 Mar;160(3):423-9.

Do T, Wade S, Anthony MS, Wagman RB, Downs RW. Medication switching in postmenopausal women on osteoporosis therapy: six-month findings from the POSSIBLE US™ Study. Poster presented at the 30th Annual Meeting of the American Society for Bone and Mineral Research; August 2008. [abstract] J Bone Miner Res. 2008 Aug 13; 23(S1):S468.

Tosteson ANA, Wade S, Anthony MS, Brancato C, Nichols S, Downs RW. Correlates of osteoporosis treatment persistence for patients new to therapy and patients with recent switches: 6-month results from POSSIBLE US. Poster presented at the 30th Annual Meeting of the American Society for Bone and Mineral Research; August 2008. [abstract] J Bone Miner Res. 2008 Aug; 23(Suppl 1):S468.

Strader C, Shinoff CW, Fitzpatrick LA, Anthony MS. Burden of hip and wrist fractures: incidence estimates of non-traumatic fractures in older women in North America, Western Europe, Australia, and Japan. Poster presented at the 29th Annual Meeting of the American Society for Bone and Mineral Research; September 2007. [abstract] J Bone Miner Res. 2007 Sep; 22(Suppl 1):S118.

Mines D, Gu Y, Novelli L, Lui Q, Gelfand J. Risk of CNS demyelinating diseases among patients with psoriasis and rheumatoid arthritis. Poster presented at the 2007 59th Annual Meeting of the American Academy of Neurology; May 2007. Boston, MA. [abstract] Neurology. 2007; 68(12, Suppl 1):A165.

Anthony MS, Stephenson JJ, Long S, Lin SL. Low prevalence of bisphosphonate therapy among long-term glucocorticoid users. Poster presented at the 28th Annual Meeting of the American Society for Bone and Mineral Research; September 2006. Philadelphia, PA. [abstract] J Bone Miner Res. 2006 Sep; 21(Suppl 1):S281.

Anthony MS, Bradbury BD, Satia JA. Diagnosed osteoporosis: the tip of the iceberg. Poster presented at the 27th Annual Meeting of the American Society for Bone and Mineral Research; August 2005. [abstract] J Bone Miner Res. 2005 Aug 11; 20(Suppl 1):S261.

Register TC, Anthony MS, Jayo MJ, Williams JK. Effects of 17ß-estradiol and consumption of phytoestrogen-rich soy or casein/lactalbumin-based diets on serum chemistries in ovariectomized female macaques. Poster presented at the 19th Annual Meeting of the American Society for Bone and Mineral Research; August 1997. [abstract] J Bone Miner Res. 1997 Aug; 12(Suppl 1):S350.

Jayo MJ, Anthony MS, Register TC, Rankin SE, Vest T, Clarkson TB. Dietary soy isoflavones and bone loss: a study in ovariectomized monkeys. Poster presented at the 18th Annual Meeting of the American Society for Bone and Mineral Research; August 1996. [abstract] J Bone Miner Res. 1996 Aug; 11(Suppl 1):S228.

Johannes CB, Linet MS, Stewart WF, Celentano DD, Lipton RB, Szklo M. Relationship of headache to phase of the menstrual cycle among young women: a daily diary study. Neurology. 1995 Jun;45(6):1076-82.